HEADER VIRAL PROTEIN 02-JUN-22 8A23 TITLE CRYSTAL STRUCTURE OF SARS-COV-2 NSP10/NSP16 METHYLTRANSFERASE IN TITLE 2 COMPLEX WITH TO383 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 2'-O-METHYLTRANSFERASE NSP16; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NON-STRUCTURAL PROTEIN 16,NSP16; COMPND 5 EC: 2.1.1.57; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: NON-STRUCTURAL PROTEIN 10; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: NSP10,GROWTH FACTOR-LIKE PEPTIDE,GFL; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 GENE: REP, 1A-1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 10 2; SOURCE 11 ORGANISM_TAXID: 2697049; SOURCE 12 GENE: REP, 1A-1B; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 14 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS VIRAL, METHYLTRANSFERASE, INHIBITOR, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.HANIGOVSKY,P.KRAFCIKOVA,M.KLIMA,E.BOURA REVDAT 2 07-FEB-24 8A23 1 REMARK REVDAT 1 14-JUN-23 8A23 0 JRNL AUTH M.HANIGOVSKY,P.KRAFCIKOVA,M.KLIMA,E.BOURA JRNL TITL CRYSTAL STRUCTURE OF SARS-COV-2 NSP10/NSP16 JRNL TITL 2 METHYLTRANSFERASE IN COMPLEX WITH TO383 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20_4459 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.78 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 15383 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.234 REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 770 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.7800 - 4.7900 1.00 3093 163 0.1980 0.2109 REMARK 3 2 4.7900 - 3.8000 0.99 2906 153 0.2215 0.2442 REMARK 3 3 3.8000 - 3.3200 1.00 2903 154 0.2437 0.2550 REMARK 3 4 3.3200 - 3.0200 1.00 2850 149 0.2820 0.3521 REMARK 3 5 3.0200 - 2.8000 1.00 2861 151 0.3101 0.3333 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.345 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.853 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 57.55 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 62.68 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 3171 REMARK 3 ANGLE : 0.461 4311 REMARK 3 CHIRALITY : 0.040 482 REMARK 3 PLANARITY : 0.004 579 REMARK 3 DIHEDRAL : 10.870 1140 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8A23 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1292123491. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-DEC-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.541870 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 200K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS XDSGUI2 REMARK 200 DATA SCALING SOFTWARE : XDS XDSGUI2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15396 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 45.780 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 12.00 REMARK 200 R MERGE (I) : 0.44750 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.0700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 12.00 REMARK 200 R MERGE FOR SHELL (I) : 3.69800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.550 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.3 REMARK 200 STARTING MODEL: 6YZ1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM SULFATE, 0.1 M SODIUM REMARK 280 ACETATE PH 5.5, 10 % W/V PEG 2000 MME, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.43700 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 42.57100 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 42.57100 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 40.71850 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 42.57100 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 42.57100 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 122.15550 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 42.57100 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 42.57100 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 40.71850 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 42.57100 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 42.57100 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 122.15550 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 81.43700 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2050 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 VAL A 139 REMARK 465 THR A 140 REMARK 465 LEU A 295 REMARK 465 VAL A 296 REMARK 465 ASN A 297 REMARK 465 ASN A 298 REMARK 465 MET B 9 REMARK 465 ASN B 10 REMARK 465 SER B 11 REMARK 465 THR B 12 REMARK 465 VAL B 13 REMARK 465 LEU B 14 REMARK 465 SER B 15 REMARK 465 PHE B 16 REMARK 465 CYS B 17 REMARK 465 ALA B 18 REMARK 465 PHE B 19 REMARK 465 ALA B 20 REMARK 465 VAL B 21 REMARK 465 ASP B 131 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 24 CD CE NZ REMARK 470 LYS A 76 CG CD CE NZ REMARK 470 LYS A 135 CE NZ REMARK 470 LYS A 137 CE NZ REMARK 470 LYS A 141 CG CD CE NZ REMARK 470 LYS A 253 CG CD CE NZ REMARK 470 LYS A 263 CG CD CE NZ REMARK 470 LYS B 25 CG CD CE NZ REMARK 470 LYS B 87 CG CD CE NZ REMARK 470 LYS B 124 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 121 49.75 -93.66 REMARK 500 LYS A 137 54.11 -90.49 REMARK 500 ASN A 210 67.23 61.84 REMARK 500 ASP B 106 71.99 -152.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 201 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 74 SG REMARK 620 2 CYS B 77 SG 112.2 REMARK 620 3 HIS B 83 NE2 106.4 93.8 REMARK 620 4 CYS B 90 SG 114.3 114.1 114.0 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 202 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 117 SG REMARK 620 2 CYS B 120 SG 105.8 REMARK 620 3 CYS B 128 SG 104.8 112.7 REMARK 620 4 CYS B 130 SG 110.5 111.2 111.5 REMARK 620 N 1 2 3 DBREF 8A23 A 1 298 UNP P0DTD1 R1AB_SARS2 6799 7096 DBREF 8A23 B 10 131 UNP P0DTD1 R1AB_SARS2 4263 4384 SEQADV 8A23 MET A 0 UNP P0DTD1 INITIATING METHIONINE SEQADV 8A23 MET B 9 UNP P0DTD1 INITIATING METHIONINE SEQRES 1 A 299 MET SER SER GLN ALA TRP GLN PRO GLY VAL ALA MET PRO SEQRES 2 A 299 ASN LEU TYR LYS MET GLN ARG MET LEU LEU GLU LYS CYS SEQRES 3 A 299 ASP LEU GLN ASN TYR GLY ASP SER ALA THR LEU PRO LYS SEQRES 4 A 299 GLY ILE MET MET ASN VAL ALA LYS TYR THR GLN LEU CYS SEQRES 5 A 299 GLN TYR LEU ASN THR LEU THR LEU ALA VAL PRO TYR ASN SEQRES 6 A 299 MET ARG VAL ILE HIS PHE GLY ALA GLY SER ASP LYS GLY SEQRES 7 A 299 VAL ALA PRO GLY THR ALA VAL LEU ARG GLN TRP LEU PRO SEQRES 8 A 299 THR GLY THR LEU LEU VAL ASP SER ASP LEU ASN ASP PHE SEQRES 9 A 299 VAL SER ASP ALA ASP SER THR LEU ILE GLY ASP CYS ALA SEQRES 10 A 299 THR VAL HIS THR ALA ASN LYS TRP ASP LEU ILE ILE SER SEQRES 11 A 299 ASP MET TYR ASP PRO LYS THR LYS ASN VAL THR LYS GLU SEQRES 12 A 299 ASN ASP SER LYS GLU GLY PHE PHE THR TYR ILE CYS GLY SEQRES 13 A 299 PHE ILE GLN GLN LYS LEU ALA LEU GLY GLY SER VAL ALA SEQRES 14 A 299 ILE LYS ILE THR GLU HIS SER TRP ASN ALA ASP LEU TYR SEQRES 15 A 299 LYS LEU MET GLY HIS PHE ALA TRP TRP THR ALA PHE VAL SEQRES 16 A 299 THR ASN VAL ASN ALA SER SER SER GLU ALA PHE LEU ILE SEQRES 17 A 299 GLY CYS ASN TYR LEU GLY LYS PRO ARG GLU GLN ILE ASP SEQRES 18 A 299 GLY TYR VAL MET HIS ALA ASN TYR ILE PHE TRP ARG ASN SEQRES 19 A 299 THR ASN PRO ILE GLN LEU SER SER TYR SER LEU PHE ASP SEQRES 20 A 299 MET SER LYS PHE PRO LEU LYS LEU ARG GLY THR ALA VAL SEQRES 21 A 299 MET SER LEU LYS GLU GLY GLN ILE ASN ASP MET ILE LEU SEQRES 22 A 299 SER LEU LEU SER LYS GLY ARG LEU ILE ILE ARG GLU ASN SEQRES 23 A 299 ASN ARG VAL VAL ILE SER SER ASP VAL LEU VAL ASN ASN SEQRES 1 B 123 MET ASN SER THR VAL LEU SER PHE CYS ALA PHE ALA VAL SEQRES 2 B 123 ASP ALA ALA LYS ALA TYR LYS ASP TYR LEU ALA SER GLY SEQRES 3 B 123 GLY GLN PRO ILE THR ASN CYS VAL LYS MET LEU CYS THR SEQRES 4 B 123 HIS THR GLY THR GLY GLN ALA ILE THR VAL THR PRO GLU SEQRES 5 B 123 ALA ASN MET ASP GLN GLU SER PHE GLY GLY ALA SER CYS SEQRES 6 B 123 CYS LEU TYR CYS ARG CYS HIS ILE ASP HIS PRO ASN PRO SEQRES 7 B 123 LYS GLY PHE CYS ASP LEU LYS GLY LYS TYR VAL GLN ILE SEQRES 8 B 123 PRO THR THR CYS ALA ASN ASP PRO VAL GLY PHE THR LEU SEQRES 9 B 123 LYS ASN THR VAL CYS THR VAL CYS GLY MET TRP LYS GLY SEQRES 10 B 123 TYR GLY CYS SER CYS ASP HET KW6 A 301 31 HET GOL A 302 6 HET ZN B 201 1 HET ZN B 202 1 HETNAM KW6 (2R,3R,4S,5R)-2-[4-AZANYL-5-(2-QUINOLIN-3-YLETHYNYL) HETNAM 2 KW6 PYRROLO[2,3-D]PYRIMIDIN-7-YL]-5-(HYDROXYMETHYL) HETNAM 3 KW6 OXOLANE-3,4-DIOL HETNAM GOL GLYCEROL HETNAM ZN ZINC ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 KW6 C22 H19 N5 O4 FORMUL 4 GOL C3 H8 O3 FORMUL 5 ZN 2(ZN 2+) HELIX 1 AA1 SER A 1 GLN A 6 5 6 HELIX 2 AA2 PRO A 12 MET A 17 1 6 HELIX 3 AA3 MET A 41 ASN A 55 1 15 HELIX 4 AA4 ALA A 79 LEU A 89 1 11 HELIX 5 AA5 ASP A 114 ALA A 116 5 3 HELIX 6 AA6 GLY A 148 LYS A 160 1 13 HELIX 7 AA7 ASN A 177 MET A 184 1 8 HELIX 8 AA8 ASP A 220 ASN A 235 1 16 HELIX 9 AA9 SER A 241 ASP A 246 5 6 HELIX 10 AB1 LYS A 263 ILE A 267 5 5 HELIX 11 AB2 ASN A 268 LYS A 277 1 10 HELIX 12 AB3 ALA B 23 SER B 33 1 11 HELIX 13 AB4 ALA B 71 CYS B 73 5 3 HELIX 14 AB5 CYS B 74 CYS B 79 1 6 HELIX 15 AB6 THR B 102 ALA B 104 5 3 HELIX 16 AB7 ASP B 106 ASN B 114 1 9 SHEET 1 AA1 8 GLY A 8 ALA A 10 0 SHEET 2 AA1 8 PHE A 187 THR A 195 -1 O VAL A 194 N VAL A 9 SHEET 3 AA1 8 ALA A 204 TYR A 211 -1 O CYS A 209 N TRP A 189 SHEET 4 AA1 8 LEU A 161 ILE A 171 -1 N ILE A 169 O LEU A 206 SHEET 5 AA1 8 TRP A 124 SER A 129 1 N TRP A 124 O ALA A 162 SHEET 6 AA1 8 ARG A 66 PHE A 70 1 N PHE A 70 O ILE A 128 SHEET 7 AA1 8 LEU A 94 ASP A 99 1 O LEU A 94 N VAL A 67 SHEET 8 AA1 8 SER A 109 ILE A 112 1 O LEU A 111 N ASP A 97 SHEET 1 AA2 2 VAL A 118 THR A 120 0 SHEET 2 AA2 2 ILE A 290 SER A 292 -1 O SER A 291 N HIS A 119 SHEET 1 AA3 2 ALA A 258 MET A 260 0 SHEET 2 AA3 2 LEU A 280 ILE A 282 1 O ILE A 281 N MET A 260 SHEET 1 AA4 3 ILE B 55 THR B 56 0 SHEET 2 AA4 3 TYR B 96 PRO B 100 -1 O TYR B 96 N THR B 56 SHEET 3 AA4 3 GLN B 65 GLY B 69 -1 N GLU B 66 O ILE B 99 LINK SG CYS B 74 ZN ZN B 201 1555 1555 2.32 LINK SG CYS B 77 ZN ZN B 201 1555 1555 2.31 LINK NE2 HIS B 83 ZN ZN B 201 1555 1555 2.06 LINK SG CYS B 90 ZN ZN B 201 1555 1555 2.32 LINK SG CYS B 117 ZN ZN B 202 1555 1555 2.32 LINK SG CYS B 120 ZN ZN B 202 1555 1555 2.33 LINK SG CYS B 128 ZN ZN B 202 1555 1555 2.33 LINK SG CYS B 130 ZN ZN B 202 1555 1555 2.33 CRYST1 85.142 85.142 162.874 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011745 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011745 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006140 0.00000